Eines der Hauptziele von Life4me+ — ist neue Fälle von HIV und anderen STIs, Hepatitis C und Tuberkulose zu verhindern.

Die App hilft, eine Kommunikation zwischen Ärzten und HIV-positiven Menschen aufzubauen. Die App erlaubt Ihnen, einen Zeitplan für Ihre Medikamenteneinnahme bequem zu organisieren – dies geschieht über eine für Dritte nicht nachvollziehbare und personalisierte Erinnerung.

Alle Nachrichten / Kann 2018

Archiv

✕

31 Mai 2018

6286

On American television will advertise PrEP

On American television will advertise PrEP

The American biopharmaceutical company Gilead Sciences will launch television advertising for the ARV drug Truvada as a means for pre-exposure prevention of HIV infection (PrEP). Representatives of Gilead said that the videos will appear on television in June and will be ...

28 Mai 2018

6701

The Swiss model of HIV prevention among drug users demonstrated high efficiency

The Swiss model of HIV prevention among drug users demonstrated high efficiency

The pragmatic policy of the Swiss in the field of HIV prevention among injecting drug users has shown extremely high efficiency. As evidenced by the data obtained by specialists from the University of Zurich and the University Hospital of Zurich, they managed to prevent ...

23 Mai 2018

7298

Chemsex is associated with an increased risk of HIV transmission and sexual infections

Chemsex is associated with an increased risk of HIV transmission and sexual infections

The use of gay, bisexual and other men who have sex with men (MSM), crystallized methamphetamine, mephedrone, γ-hydroxybutyrate or γ-butyrolactone, and to a lesser extent cocaine and ketamine during sexual intercourse, or the so-called " the phenomenon is relatively new, ...

22 Mai 2018

7465

ART drug Juluca appears in European pharmacies

ART drug Juluca appears in European pharmacies

Pharmaceutical company ViiV Healthcare, specializing in the development and production of medicines for HIV treatment, reported that the European Commission issued a permit for the implementation in Europe of the combined drug Juluca. Juluca is a two drug regimen made up ...

17 Mai 2018

7014

Truvada in the US will be used to reduce the risk of HIV transmission among adolescents

Truvada in the US will be used to reduce the risk of HIV transmission among adolescents

Gilead Sciences, Inc. announced that the FDA approved once-daily oral emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (Truvada) in combination with safe sex practices, to reduce the risk of sexually acquired HIV-1 in at-risk adolescents.

1 Mai 2018

9735

A patient has died from AIDS in Switzerland because he was not paid for HIV treatment

A patient has died from AIDS in Switzerland because he was not paid for HIV treatment

As it became known to the media, an HIV-positive patient died from AIDS in Switzerland in the end of 2017. He was being refused of a medical treatment due to missing necessary health insurance, and the insurance company refused several times to pay for the treatment because ...